Godavari Drugs

Godavari Drugs EBITDA per Share

The EBITDA per Share of Godavari Drugs (530317.BO) as of Oct 26, 2026 is 8.42 INR. In the previous year, EBITDA per Share was 11.68 INR — a change of -27.92% (lower).

EBITDA per Share

8.42INR

YoY

-27.92%

Last updated:

EBITDA per Share of Godavari Drugs is 2026 8.42 INR. EBITDA per Share of Godavari Drugs was 2025 11.68 INR. It decreases by -27.92% lower compared to the previous year.

The Godavari Drugs EBITDA per Share history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA per Share
Date
EBITDA per Share
Jan 1, 2019
5.41 INR
Jan 1, 2020
5.96 INR
Jan 1, 2021
9.70 INR
Jan 1, 2022
11.15 INR
Jan 1, 2023
10.02 INR
Jan 1, 2024
13.66 INR
Jan 1, 2025
11.68 INR
Jan 1, 2026
8.42 INR
The Godavari Drugs EBITDA per Share history
YEAREBITDA per ShareYoY
8.42INR-27.92%
11.68INR-14.49%
13.66INR+36.27%
10.02INR-10.09%
11.15INR+14.89%
9.70INR+62.82%
5.96INR+10.17%
5.41INR+35.59%
3.99INR-42.47%
6.93INR+16.17%
5.97INR+4.51%
5.71INR+213.57%
1.82INR—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Godavari Drugs Stock analysis

What does Godavari Drugs do? Godavari Drugs Ltd, based in Secunderabad, Telangana, manufactures active pharmaceutical ingredients (APIs) and intermediates for the global life science industry. The company operates facilities in Nanded, Maharashtra, producing APIs such as Ciprofloxacin HCl and Mefenamic Acid, along with intermediates like A D Lactone and 6 Mercaptopurine. It partners with multinational firms through contract manufacturing and holds active loan licenses for API production. Godavari Drugs is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Godavari Drugs stock

EBITDA per Share of Godavari Drugs is 8.42 INR in 2026.

EBITDA per Share of Godavari Drugs changed from 11.68 INR to 8.42 INR, representing a -27.92% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA per Share Godavari Drugs since 2006 – with annual values, charts, and detailed analysis.

EBITDA per share divides EBITDA by shares outstanding, showing the operating cash earnings allocated to each share before depreciation and financing effects.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Get Free API Key

Income Statement — Godavari Drugs

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Godavari Drugs